Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma

1 Pogledi
administrator
administrator
08/09/23

Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći